Erschienen in:

01.07.1997 | ORIGINAL ARTICLE

Randomized trial comparing the tolerability of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in cancer patients receiving myelosuppressive chemotherapy

verfasst von: R. A. Beveridge, John A. Miller, Arthur N. Kales, Richard A. Binder, Nicholas J. Robert, Janet Heisrath-Evans, Kathy Koczyk-Scripka, Steven Pashko, Michael J. Norgard, Harry M. Barnes, William R. Taylor, Keith A. Thompson, L. F. Smith, Winston M. Ueno, Robert F. Dobrzynski, Robert D. Warren, Daniel Katcher, Patrick J. Byrne, David M. Dunning, Stanley H. Winokur, Julian L. Lockey, Richard J. Cambareri, Thomas P. Butler, Robert J. Meister, John M. Fiegert

Erschienen in: Supportive Care in Cancer | Ausgabe 4/1997